Bridgett Loren Miracle, - Medicare Occupational Therapist in Somerset, KY

Bridgett Loren Miracle, is a medicare enrolled "Occupational Therapist" provider in Somerset, Kentucky. Her current practice location is 303 Second St, Somerset, Kentucky. You can reach out to her office (for appointments etc.) via phone at (606) 677-1166.

Bridgett Loren Miracle is licensed to practice in Kentucky (license number 174748) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1184143927.

Contact Information

Bridgett Loren Miracle,
303 Second St,
Somerset, KY 42501-2390
(606) 677-1166
(606) 677-0693



Healthcare Provider's Profile

Full NameBridgett Loren Miracle
GenderFemale
SpecialityOccupational Therapist
Location303 Second St, Somerset, Kentucky
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1184143927
  • Provider Enumeration Date: 09/13/2017
  • Last Update Date: 09/13/2017
  Medicare PECOS Information:
  • PECOS PAC ID: 3779858816
  • Enrollment ID: I20170929000738

Medical Identifiers

Medical identifiers for Bridgett Loren Miracle such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1184143927NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
225X00000XOccupational Therapist 174748 (Kentucky)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Bridgett Loren Miracle allows following entities to bill medicare on her behalf.
Provider NameBrighter Futures Therapy Center Llc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1598186868
PECOS PAC ID: 2668742107
Enrollment ID: O20170717002037

News Archive

Allos reports topline results from Phase 2b trial of FOLOTYN vs erlotinib in advanced NSCLC

Allos Therapeutics, Inc. today announced topline results from the Company's randomized Phase 2b investigational trial of FOLOTYN® (pralatrexate injection) versus erlotinib in patients with Stage IIIB/IV (advanced) non-small cell lung cancer (NSCLC) who had received one or two prior systemic treatments including at least one prior platinum-based regimen. The objective of the trial was to estimate the efficacy of FOLOTYN compared to that of erlotinib as assessed by overall survival.

BIOTRONIK launches its new, unified platform pacemaker series in Europe

BIOTRONIK SE & Co. KG, the pioneer of wireless remote monitoring technologies and leading manufacturer of implantable cardiac devices, today announced the European launch of its new, unified platform pacemaker series, Evia, and several new products to further strengthen its bradycardia portfolio.

Metabolomx' colorimetric sensor array can identify subtype of lung cancer

Metabolomx, a diagnostic company focused on the detection of the metabolomics signature of cancer from exhaled breath, today announces publication of results from the first clinical study demonstrating a breath test that can both detect lung cancer and differentiate between types of lung cancer in humans.

Calibra Medical's Finesse insulin patch-pen receives FDA clearance for use with Novo Nordisk's Novolog

Calibra Medical announced today it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Finesse™ insulin patch-pen for up to three-day use with Novo Nordisk's Novolog® rapid acting insulin. Combining the mealtime therapy-adherence benefits of insulin pumps with the simplicity and affordability of syringes and pens, Calibra's novel bolus-only patch-pen is a small, adhesively attached, flat device that can be operated discretely through clothing to deliver mealtime, snack time, and correction bolus insulin in seconds.

PEPFAR shows how working across 'political spectrum' can prove successful

"Thirty years since the first case of AIDS was diagnosed in the United States, the world finds itself at a tipping point in the fight against this deadly disease," U.S. Global AIDS Coordinator Ambassador Eric Goosby and George W. Bush Inaugural Global Health Fellow Ambassador Mark Dybul, who served as global AIDS coordinator from 2006 to 2009, write in a Huffington Post opinion piece.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Bridgett Loren Miracle is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Bridgett Loren Miracle,
58 Mill Creek Dr,
Corbin, KY 40701-4182

Ph: (606) 677-1166
Bridgett Loren Miracle,
303 Second St,
Somerset, KY 42501-2390

Ph: (606) 677-1166

News Archive

Allos reports topline results from Phase 2b trial of FOLOTYN vs erlotinib in advanced NSCLC

Allos Therapeutics, Inc. today announced topline results from the Company's randomized Phase 2b investigational trial of FOLOTYN® (pralatrexate injection) versus erlotinib in patients with Stage IIIB/IV (advanced) non-small cell lung cancer (NSCLC) who had received one or two prior systemic treatments including at least one prior platinum-based regimen. The objective of the trial was to estimate the efficacy of FOLOTYN compared to that of erlotinib as assessed by overall survival.

BIOTRONIK launches its new, unified platform pacemaker series in Europe

BIOTRONIK SE & Co. KG, the pioneer of wireless remote monitoring technologies and leading manufacturer of implantable cardiac devices, today announced the European launch of its new, unified platform pacemaker series, Evia, and several new products to further strengthen its bradycardia portfolio.

Metabolomx' colorimetric sensor array can identify subtype of lung cancer

Metabolomx, a diagnostic company focused on the detection of the metabolomics signature of cancer from exhaled breath, today announces publication of results from the first clinical study demonstrating a breath test that can both detect lung cancer and differentiate between types of lung cancer in humans.

Calibra Medical's Finesse insulin patch-pen receives FDA clearance for use with Novo Nordisk's Novolog

Calibra Medical announced today it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Finesse™ insulin patch-pen for up to three-day use with Novo Nordisk's Novolog® rapid acting insulin. Combining the mealtime therapy-adherence benefits of insulin pumps with the simplicity and affordability of syringes and pens, Calibra's novel bolus-only patch-pen is a small, adhesively attached, flat device that can be operated discretely through clothing to deliver mealtime, snack time, and correction bolus insulin in seconds.

PEPFAR shows how working across 'political spectrum' can prove successful

"Thirty years since the first case of AIDS was diagnosed in the United States, the world finds itself at a tipping point in the fight against this deadly disease," U.S. Global AIDS Coordinator Ambassador Eric Goosby and George W. Bush Inaugural Global Health Fellow Ambassador Mark Dybul, who served as global AIDS coordinator from 2006 to 2009, write in a Huffington Post opinion piece.

Read more News

› Verified 7 days ago


Occupational Therapist in Somerset, KY

April Lasha Bussell, OTR/L
Occupational Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 175 Medpark Dr, Somerset, KY 42503
Phone: 606-679-1761    
Mrs. Trena Schultz, OTR/L, CHT
Occupational Therapist
Medicare: Accepting Medicare Assignments
Practice Location: 175 Medpark Dr, Somerset, KY 42503
Phone: 606-679-1761    Fax: 606-678-0971
Mrs. Megan M Angel, OTR/L
Occupational Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 303 Second St, Somerset, KY 42501
Phone: 606-679-1166    
Alicia Garland,
Occupational Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 555 Bourne Ave, Somerset, KY 42501
Phone: 606-679-7421    
Mrs. Nicole L Blevins, OTR/L
Occupational Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 353 Bogle St, Suite 203, Somerset, KY 42503
Phone: 606-679-1761    Fax: 606-678-0971
Mrs. Leslie Anne Preston, OTR/L
Occupational Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 555 Bourne Ave, Somerset, KY 42501
Phone: 606-679-7421    
Keirstyn Shaye Morton, OTD, OTR/L
Occupational Therapist
Medicare: Medicare Enrolled
Practice Location: 175 Medpark Dr, Somerset, KY 42503
Phone: 606-679-1761    Fax: 606-678-0971

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.